BABA
Alibaba Group Holding Limited
BABA's fundamentals are weak: its operating margin fell 10 points to 4.2% and free cash flow turned negative, though revenue grew 4.3%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
EMPD
Empery Digital Inc.
There isn't enough reported data to score EMPD yet.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
EMPD Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
EMPD's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | โ |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
EMPD PE Valuation
EMPD has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 51x next year's earnings.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
EMPD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect EMPD to return to profit, with revenue declining.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over EMPD in the latest year-over-year earnings comparison.
EMPD Earnings Per Share
EMPD lost $9.22 per share over the past year, a smaller loss than the year before.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over EMPD on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA's operating margin was 7.2% last quarter, down 6.9 points from the same quarter a year ago.
EMPD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $99.6K | -50% |
| Q2 2026 | $80K | -89% |
| Q1 2026 | $225.7K | -69% |
| Q3 2025 | $198.3K | -82% |
| Q2 2025 | $702.9K | -25% |
| Q1 2025 | $736K | -29% |
| Q4 2024 | $986.9K | -8.9% |
| Q3 2024 | $1.1M | +121% |
EMPD's revenue has slid since its 2022 peak: $99,606 last quarter, down 50% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24458% | +41847 points |
| Q2 2026 | -52573% | -52022 points |
| Q1 2026 | -36912% | -36572 points |
| Q3 2025 | -17389% | -16261 points |
| Q2 2025 | -551% | +37 points |
| Q1 2025 | -341% | +70 points |
| Q4 2024 | -517% | +395 points |
| Q3 2024 | -1128% | +812 points |
EMPD has the edge over BABA on profitability, with a higher operating margin.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: โ$11.6B over the past year.
EMPD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$15M | -$7.3M |
| Q2 2026 | -$6.9M | -$3.2M |
| Q1 2026 | -$3.5M | +$251.5K |
| Q4 2025 | -$3M | +$807.6K |
| Q3 2025 | -$7.6M | -$3.5M |
| Q2 2025 | -$3.7M | +$118.8K |
| Q1 2025 | -$3.8M | +$899.3K |
| Q4 2024 | -$3.8M | +$9.1M |
EMPD has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
EMPD Net Leverage
EMPD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
EMPD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 23.3 | Oversold |
| Stochastic | 8.5 | Oversold |
EMPD's weekly RSI is 23 (oversold) and its Stochastic is 8 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
EMPD PE vs Consumer Cyclical Sector
EMPD has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
EMPD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.68 | 24% below |
| 20 week MA | $3.00 | 32% below |
| 50 week MA | $3.83 | 47% below |
| 100 week MA | $7.20 | 72% below |
| 200 week MA | $280,582.3 | 100% below |
EMPD is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over EMPD on returns for 2026, with the stronger performance.
EMPD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $13,147,200.0 | $12,297,600.0 | -6.5% |
| 2022 | $12,297,600.0 | $1,339,200.0 | -89% |
| 2023 | $1,339,200.0 | $28,512.0 | -98% |
| 2024 | $28,512.0 | $32.2 | -100% |
| 2025 | $32.2 | $4.35 | -87% |
| 2026 YTD | $4.35 | $2.03 | -53% |
EMPD has finished every year since 2021 lower, and it's down 53% so far in 2026.